About CH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Federation Francophone de Cancerologie Digestive
4
GERCOR - Multidisciplinary Oncology Cooperative Group
4
Acute Leukemia French Association
3
Centre Hospitalier Intercommunal Creteil
2
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
2
French Society for Intensive Care
2
UNICANCER
2
University Hospital, Lille
2
ANRS, Emerging Infectious Diseases
1
Centre Francois Baclesse
1
Centre Hospitalier Departemental Vendee
1
Clinical Trials at CH
During the past decade, CH conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
1995-02-01
Completed
3,300
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
2001-06-01
2009-12-01
Completed
3,010
Combination Chemotherapy in Treating Women With Stage I Breast Cancer
2002-08-01
2013-06-01
Completed
1,512
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
2003-09-01
2021-05-31
Completed
2,980
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
2003-11-01
Unknown status
Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)
2005-05-01
Completed
700
Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery
2006-05-01
Completed
3,400
Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
2008-02-01
2014-09-01
Completed
820
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CH" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 4 trials, followed by "GERCOR - Multidisciplinary Oncology Cooperative Group" with 4 trials
sponsored, "Acute Leukemia French Association" with 3 trials sponsored, "Centre Hospitalier Intercommunal Creteil" with 2 trials sponsored and "Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer"
with 2 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CH"
#1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "CHU Nantes" with 1 trials as a collaborator and "Cancer Research UK" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at CH
According to Clinical.Site data, the most researched conditions in "CH" are
"Breast Cancer" (4 trials), "Acute Myeloid Leukemia" (3 trials), "Colorectal Cancer" (2 trials), "Critical Care" (2 trials) and "Intensive Care Unit Syndrome" (2 trials). Many other conditions were trialed in "CH" in a lesser frequency.
Clinical Trials Intervention Types at CH
Most popular intervention types in "CH" are "Drug" (18 trials), "Other" (6 trials), "Biological" (3 trials), "Radiation" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "bevacizumab" (2 trials), "fluorouracil" (2 trials), "gemcitabine hydrochloride" (2 trials), "radiation therapy" (2 trials) and "5-FU/LV" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CH
The vast majority of trials in "CH" are
25 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at CH
Currently, there are NaN active trials in "CH".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in CH,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in CH, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of CH
CH has several departments that took part in Clinical trials: "Service de Pneumologie" - 2 trials
Departments List
Name
City
Trials